多模态人工智能在前列腺癌影像中的整合应用
本综述总结以多参数MRI为中心的多模态AI在前列腺癌中的深度学习架构、融合策略、代表应用与实施挑战。当前证据最强的是MRI与常规临床变量结合,较单一模态模型有增量判别、校准或净获益。跨模态整合超声与PSMA PET可能辅助活检定位和局部分期,但需解决域偏移、验证与治理问题。
要点
- MRI结合常规临床变量是目前证据最强的多模态组合,阅片时可关注此类模型输出。
- 超声与PSMA PET跨模态整合可能辅助活检定位和局部分期。
- 多模态AI输出存在幻觉与外部验证风险,不能自主用于临床决策。
核心结论
- 多模态AI通过整合mpMRI与临床、病理、基因组、超声及PSMA PET数据,正在超越单纯MRI模型。
- 跨模态整合有望支持活检定位、局部分期和预后判断,但距离临床转化仍需解决验证和治理问题。
- 在防护措施下,多模态AI可能成为前列腺癌精准诊疗的有用组成部分。
研究设计与样本
- 本文为综述,总结深度学习架构、融合策略、代表性应用及实施挑战。
- 涵盖卷积神经网络、U-Net变体、Transformer、注意力模块和生成对抗网络等技术。
- 评价证据范围包括MRI与临床变量、超声、PSMA PET、病理及主动监测等应用。
诊断标准与关键数值
- MRI与常规临床变量结合的研究显示相对于单一模态模型有增量判别、校准或净获益。
- 跨模态超声与PSMA PET整合可能支持活检定位和局部分期。
- 病理与临床融合可能支持预后判断。
临床应用与阅片要点
- 阅片和报告时可将AI输出作为辅助参考,并注意其输入模态的透明披露。
- 注意不同机构、扫描设备、协议、示踪剂和病理流程造成的域偏移问题。
- 不能仅依赖多模态AI输出,需结合概率校准、不确定性估计和多学科治理。
局限性
- 跨机构、扫描仪、协议、示踪剂、病理流程和患者人群的域偏移是核心障碍。
- 标注和结局定义的异质性限制了模型的可推广性。
- 基础模型和大语言模型存在幻觉、来源、隐私和外部验证问题,不能自主使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Multimodal artificial intelligence (AI) is reshaping prostate cancer imaging by moving beyond MRI-only algorithms toward models that integrate multiparametric MRI (mpMRI) with clinical variables, pathology, genomics, ultrasound, and prostate-specific membrane antigen (PSMA) positron emission tomography (PET). This review summarizes the deep-learning architectures, fusion strategies, representative applications, and implementation challenges of mpMRI-centered multimodal AI. Convolutional neural networks and U-Net variants remain central to image encoding and segmentation; transformers and attention modules support cross-modal interaction, whereas generative adversarial networks are used mainly for augmentation, synthesis, and image restoration. Current evidence is strongest for combining MRI with routinely available clinical variables, for which several studies have reported incremental discrimination, calibration, or net benefit relative to single-modality models. Cross-modality integration with ultrasound and PSMA PET may support biopsy targeting and local staging, whereas pathology-clinical fusion may support prognosis. Foundation models and large language models may facilitate transferable representation learning and conversion of unstructured reports and clinical notes into structured multimodal inputs, but hallucination, provenance, privacy, and external-validation concerns preclude autonomous use. Active surveillance is an emerging longitudinal application because serial MRI, PSA kinetics, repeat biopsy, and patient-level outcomes must be aligned over time. However, domain shift across institutions, scanners, protocols, tracers, pathology workflows, and patient populations, together with labeling and outcome-definition heterogeneity, remains a central barrier. Translation into practice will require modality-specific harmonization, leakage-resistant validation, missing-modality robustness, probability calibration, uncertainty estimation, transparent disclosure of input availability and model provenance, prospective impact studies, and multidisciplinary governance. With these safeguards, multimodal AI may become a useful component of precision prostate cancer care.
引用
- Fujiwara, Yoshida, Banerjee, et al. Multimodal artificial intelligence in prostate cancer: integrating multiparametric MRI with clinicopathological, molecular, and functional imaging data. Abdom Radiol (NY). 2026. PMID: 42635792. doi:10.1007/s00261-026-05723-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。